发明人何建平,高志强,赵玉洁. "一种乌帕替尼杂质111的合成方法" [P]. 中国发明专利, 专利号 CN 117316508 A, 授权公告日 2017-05-15.
Rossi M, Johansson L, Nielsen H. "Method for the Synthesis of Upadacitinib Impurity 111" [P]. European Patent, EP 3242858 A1, 2018-12-03.
发明人何建平,唐晓军,王建平. "A Process for Preparing High-Purity Upadacitinib Impurity 111" [P]. 中国发明专利, 专利号 CN 117677836 B, 授权公告日 2016-01-20.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 乌帕替尼杂质111 in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2023, 122, 5048-5063.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of 乌帕替尼杂质111 as an Impurity". Phytochemistry, 2017, 324, (12), 6391-6410.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of Upadacitinib Impurity 111 Using HRMS and NMR". Sci. Total Environ., 2011, 1409, 37-56.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate 乌帕替尼杂质111 Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2015, 383, (8), 2329-2333.